35.24
price down icon0.45%   -0.16
 
loading

Xoma Royalty Corp Azioni (XOMA) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
82.60%
15.91
8.714 7.197 11.09 1.49
Operating Expenses
37.48%
9.983
15.97 22.84 21.16 8.494
Benefits Costs and Expenses
26.15%
13.54
18.34 - - 10.09
Costs And Expenses
26.15%
13.54
18.34 22.84 21.16 10.09
Operating Income/Loss
181.75%
5.929
-7.253 -15.64 -10.08 -7.004
Income/Loss From Continuing Operations Before Tax
124.59%
2.367
-9.626 7.197 15.98 -8.595
Income Tax Expense/Benefit
100.00%
-
-5.658 - - -
Income/Loss From Continuing Operations After Tax
159.65%
2.367
-3.968 -17.24 15.98 -8.595
Net Income/Loss
159.65%
2.367
-3.968 -17.24 15.98 -8.595
Preferred Stock Dividends And Other Adjustments
21.49%
1.662
1.368 1.368 - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
21,273%
11.97
0.056 11.71 11.64 0.0116
Diluted Average Shares
31,652%
17.78
0.056 11.71 17.32 0.0116
Basic Earnings Per Share
113.33%
0.06
-0.45 -1.59 0.88 -0.86
Diluted Earnings Per Share
113.33%
0.06
-0.45 -1.59 0.84 -0.86
Undistributed Earnings/Loss Allocated To Participating Securities, Basic
0.294
- - 4.393 -2.992
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
42.98%
1.956
1.368 1.368 - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Capitalizzazione:     |  Volume (24 ore):